LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC announces that a class action lawsuit has been filed in the United States District Court for the Central District of California against Puma Biotechnology, Inc. (“Puma” or the “Company”) (NYSE: PBYI), for alleged violations of the federal securities laws. Investors who purchased or otherwise acquired shares between July 23, 2014 and May 13, 2015, inclusive (the “Class Period”), have until August 3, 2015 to serve as lead plaintiff in the class action